"Agoraphobia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Obsessive, persistent, intense fear of open places.
Descriptor ID |
D000379
|
MeSH Number(s) |
F03.080.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Agoraphobia".
Below are MeSH descriptors whose meaning is more specific than "Agoraphobia".
This graph shows the total number of publications written about "Agoraphobia" by people in this website by year, and whether "Agoraphobia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1998 | 0 | 2 | 2 |
1999 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2011 | 1 | 1 | 2 |
2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Agoraphobia" by people in Profiles.
-
Face Perception in Social Anxiety: Visuocortical Dynamics Reveal Propensities for Hypervigilance or Avoidance. Biol Psychiatry. 2018 04 01; 83(7):618-628.
-
A preliminary investigation of the effects of cognitive behavioral therapy for panic disorder on gastrointestinal distress in patients with comorbid panic disorder and irritable bowel syndrome. Depress Anxiety. 2011 Nov; 28(11):1027-33.
-
Aversive imagery in panic disorder: agoraphobia severity, comorbidity, and defensive physiology. Biol Psychiatry. 2011 Sep 01; 70(5):415-24.
-
Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder. J Affect Disord. 2009 Jan; 112(1-3):262-6.
-
Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301.
-
Self-reported symptoms of social anxiety in a sample of combat veterans with posttraumatic stress disorder. J Anxiety Disord. 1998 Nov-Dec; 12(6):605-12.
-
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998 Jan; 155(1):36-42.
-
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6.
-
Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia. Br J Psychiatry. 1993 Jun; 162:788-9; discussion 790-4.
-
Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry. 1992 Nov; 149(11):1556-62.